<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34968409</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>06</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>06</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1938-2022</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>14</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
              <Day>31</Day>
            </PubDate>
          </JournalIssue>
          <Title>Islets</Title>
          <ISOAbbreviation>Islets</ISOAbbreviation>
        </Journal>
        <ArticleTitle>LDB1-mediated transcriptional complexes are sensitive to islet stress.</ArticleTitle>
        <Pagination>
          <StartPage>58</StartPage>
          <EndPage>68</EndPage>
          <MedlinePgn>58-68</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/19382014.2021.2016028</ELocationID>
        <Abstract>
          <AbstractText>Excess nutrients and proinflammatory cytokines impart stresses on pancreatic islet β-cells that, if unchecked, can lead to cellular dysfunction and/or death. Among these stress-induced effects is loss of key β-cell transcriptional regulator mRNA and protein levels required for β-cell function. Previously, our lab and others reported that LIM-domain complexes comprised the LDB1 transcriptional co-regulator and Islet-1 (ISL1) transcription factor are required for islet β-cell development, maturation, and function. The LDB1:ISL1 complex directly occupies and regulates key β-cell genes, including <i>MafA, Pdx1</i>, and <i>Slc2a2</i>, to maintain β-cell identity and function. Given the importance of LDB1:ISL1 complexes, we hypothesized that LDB1 and/or ISL1 levels, like other transcriptional regulators, are sensitive to β-cell nutrient and cytokine stresses, likely contributing to β-cell (dys)function under various stimuli. We tested this by treating β-cell lines or primary mouse islets with elevating glucose concentrations, palmitate, or a cytokine cocktail of IL-1β, TNFα, and IFNγ. We indeed observed that LDB1 mRNA and/or protein levels were reduced upon palmitate and cytokine (cocktail or singly) incubation. Conversely, acute high glucose treatment of β-cells did not impair LDB1 or ISL1 levels, but increased LDB1:ISL1 interactions. These observations suggest that LDB1:ISL1 complex formation is sensitive to β-cell stresses and that targeting and/or stabilizing this complex may rescue lost β-cell gene expression to preserve cellular function.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Yanping</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Division of Endocrinology Diabetes and Metabolism University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Comprehensive Diabetes Center, University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kepple</LastName>
            <ForeName>Jessica D</ForeName>
            <Initials>JD</Initials>
            <Identifier Source="ORCID">0000-0002-0600-2045</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Division of Endocrinology Diabetes and Metabolism University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Comprehensive Diabetes Center, University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shalev</LastName>
            <ForeName>Anath</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Division of Endocrinology Diabetes and Metabolism University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Comprehensive Diabetes Center, University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>S Hunter</LastName>
            <ForeName>Chad</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">0000-0002-1644-447X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Division of Endocrinology Diabetes and Metabolism University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Comprehensive Diabetes Center, University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>F31 DK121414</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK111483</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK128132</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Islets</MedlineTA>
        <NlmUniqueID>101495366</NlmUniqueID>
        <ISSNLinking>1938-2014</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D060588">LIM Domain Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D060850">LIM-Homeodomain Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C102084">Ldb1 protein, mouse</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010168">Palmitates</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>IY9XDZ35W2</RegistryNumber>
          <NameOfSubstance UI="D005947">Glucose</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D060588" MajorTopicYN="Y">LIM Domain Proteins</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D060850" MajorTopicYN="N">LIM-Homeodomain Proteins</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010168" MajorTopicYN="N">Palmitates</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014157" MajorTopicYN="Y">Transcription Factors</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Transcription factor</Keyword>
        <Keyword MajorTopicYN="Y">co-regulator</Keyword>
        <Keyword MajorTopicYN="Y">cytokine</Keyword>
        <Keyword MajorTopicYN="Y">diabetes</Keyword>
        <Keyword MajorTopicYN="Y">glucose</Keyword>
        <Keyword MajorTopicYN="Y">islet</Keyword>
        <Keyword MajorTopicYN="Y">palmitate</Keyword>
        <Keyword MajorTopicYN="Y">pancreas</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the authors.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>30</Day>
          <Hour>20</Hour>
          <Minute>10</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>31</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34968409</ArticleId>
        <ArticleId IdType="pmc">PMC8726731</ArticleId>
        <ArticleId IdType="doi">10.1080/19382014.2021.2016028</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Accili D.
Lilly lecture 2003: the struggle for mastery in insulin action: from triumvirate to republic. Diabetes. 2004;53(7):1633–1642. doi:10.2337/diabetes.53.7.1633.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diabetes.53.7.1633</ArticleId>
            <ArticleId IdType="pubmed">15220184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature. 2010;464:1293–1300. doi:10.1038/nature08933.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature08933</ArticleId>
            <ArticleId IdType="pmc">PMC4959889</ArticleId>
            <ArticleId IdType="pubmed">20432533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hunter CS, Stein RW. Evidence for loss in identity, de-differentiation, and trans-differentiation of islet beta-cells in type 2 diabetes. Front Genet. 2017;8:35. doi:10.3389/fgene.2017.00035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fgene.2017.00035</ArticleId>
            <ArticleId IdType="pmc">PMC5372778</ArticleId>
            <ArticleId IdType="pubmed">28424732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roep BO, Thomaidou S, van Tienhoven R, Zaldumbide A. Type 1 diabetes mellitus as a disease of the beta-cell (do not blame the immune system?). Nat Rev Endocrinol. 2021;17:150–161. doi:10.1038/s41574-020-00443-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41574-020-00443-4</ArticleId>
            <ArticleId IdType="pmc">PMC7722981</ArticleId>
            <ArticleId IdType="pubmed">33293704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harmon JS, Stein R, Robertson RP. Oxidative stress-mediated, post-translational loss of MafA protein as a contributing mechanism to loss of insulin gene expression in glucotoxic beta cells. J Biol Chem. 2005;280:11107–11113. doi:10.1074/jbc.M410345200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M410345200</ArticleId>
            <ArticleId IdType="pubmed">15664999</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kataoka K, Han SI, Shioda S, Hirai M, Nishizawa M, Handa H. MafA is a glucose-regulated and pancreatic beta-cell-specific transcriptional activator for the insulin gene. J Biol Chem. 2002;277:49903–49910. doi:10.1074/jbc.M206796200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M206796200</ArticleId>
            <ArticleId IdType="pubmed">12368292</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raum JC, Hunter CS, Artner I, Henderson E, Guo M, Elghazi L, Sosa-Pineda B, Ogihara T, Mirmira RG, Sussel L, et al. Islet beta-cell-specific MafA transcription requires the 5ʹ-flanking conserved region 3 control domain. Mol Cell Biol. 2010;30:4234–4244. doi:10.1128/MCB.01396-09.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.01396-09</ArticleId>
            <ArticleId IdType="pmc">PMC2937551</ArticleId>
            <ArticleId IdType="pubmed">20584984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vanderford NL, Andrali SS, Ozcan S. Glucose induces MafA expression in pancreatic beta cell lines via the hexosamine biosynthetic pathway. J Biol Chem. 2007;282(3):1577–1584. doi:10.1074/jbc.M605064200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M605064200</ArticleId>
            <ArticleId IdType="pmc">PMC1904346</ArticleId>
            <ArticleId IdType="pubmed">17142462</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao L, Guo M, Matsuoka TA, Hagman DK, Parazzoli SD, Poitout V, Stein R. The islet beta cell-enriched MafA activator is a key regulator of insulin gene transcription. J Biol Chem. 2005;280:11887–11894. doi:10.1074/jbc.M409475200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M409475200</ArticleId>
            <ArticleId IdType="pubmed">15665000</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chin-Chance CV, Newman MV, Aronovitz A, Blomeier H, Kruger J, Lee EJ, Lowe WL. Role of the mitogen-activated protein kinases in cytokine-mediated inhibition of insulin gene expression. J Investig Med. 2006;54:132–142. doi:10.2310/6650.2006.05035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2310/6650.2006.05035</ArticleId>
            <ArticleId IdType="pubmed">16948396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oetjen E, Blume R, Cierny I, Schlag C, Kutschenko A, Kratzner R, Stein R, Knepel W. Inhibition of MafA transcriptional activity and human insulin gene transcription by interleukin-1beta and mitogen-activated protein kinase kinase kinase in pancreatic islet beta cells. Diabetologia. 2007;50:1678–1687. doi:10.1007/s00125-007-0712-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00125-007-0712-2</ArticleId>
            <ArticleId IdType="pubmed">17583797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shao C, Lawrence MC, Cobb MH. Regulation of CCAAT/enhancer-binding protein homologous protein (CHOP) expression by interleukin-1 beta in pancreatic beta cells. J Biol Chem. 2010;285:19710–19719. doi:10.1074/jbc.M109.087486.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M109.087486</ArticleId>
            <ArticleId IdType="pmc">PMC2888381</ArticleId>
            <ArticleId IdType="pubmed">20424162</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo S, Dai C, Guo M, Taylor B, Harmon JS, Sander M, Robertson RP, Powers AC, Stein R. Inactivation of specific beta cell transcription factors in type 2 diabetes. J Clin Invest. 2013;123:3305–3316. doi:10.1172/JCI65390.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI65390</ArticleId>
            <ArticleId IdType="pmc">PMC3726150</ArticleId>
            <ArticleId IdType="pubmed">23863625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsuoka TA, Kaneto H, Miyatsuka T, Yamamoto T, Yamamoto K, Kato K, Shimomura I, Stein R, Matsuhisa M. Regulation of MafA expression in pancreatic beta-cells in db/db mice with diabetes. Diabetes. 2010;59:1709–1720. doi:10.2337/db08-0693.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db08-0693</ArticleId>
            <ArticleId IdType="pmc">PMC2889771</ArticleId>
            <ArticleId IdType="pubmed">20424231</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hang Y, Stein R. MafA and MafB activity in pancreatic beta cells. Trends Endocrinol Metab. 2011;22:364–373. doi:10.1016/j.tem.2011.05.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tem.2011.05.003</ArticleId>
            <ArticleId IdType="pmc">PMC3189696</ArticleId>
            <ArticleId IdType="pubmed">21719305</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Robertson RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem. 2004;279(41):42351–42354. doi:10.1074/jbc.R400019200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.R400019200</ArticleId>
            <ArticleId IdType="pubmed">15258147</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Du A, Hunter CS, Murray J, Noble D, Cai CL, Evans SM, Stein R, May CL. Islet-1 is required for the maturation, proliferation, and survival of the endocrine pancreas. Diabetes. 2009;58:2059–2069. doi:10.2337/db08-0987.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db08-0987</ArticleId>
            <ArticleId IdType="pmc">PMC2731519</ArticleId>
            <ArticleId IdType="pubmed">19502415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ediger BN, Du A, Liu J, Hunter CS, Walp ER, Schug J, Kaestner KH, Stein R, Stoffers DA, May CL, et al. Islet-1 Is essential for pancreatic beta-cell function. Diabetes. 2014;63:4206–4217. doi:10.2337/db14-0096.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db14-0096</ArticleId>
            <ArticleId IdType="pmc">PMC4237994</ArticleId>
            <ArticleId IdType="pubmed">25028525</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ediger BN, Lim HW, Juliana C, Groff DN, Williams LT, Dominguez G, Liu J-H, Taylor BL, Walp ER, Kameswaran V, et al. LIM domain-binding 1 maintains the terminally differentiated state of pancreatic beta cells. J Clin Invest. 2017;127:215–229. doi:10.1172/JCI88016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI88016</ArticleId>
            <ArticleId IdType="pmc">PMC5199701</ArticleId>
            <ArticleId IdType="pubmed">27941246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hunter CS, Dixit S, Cohen T, Ediger B, Wilcox C, Ferreira M, Westphal H, Stein R, May CL. Islet alpha-, beta-, and delta-cell development is controlled by the Ldb1 coregulator, acting primarily with the islet-1 transcription factor. Diabetes. 2013;62:875–886. doi:10.2337/db12-0952.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db12-0952</ArticleId>
            <ArticleId IdType="pmc">PMC3581213</ArticleId>
            <ArticleId IdType="pubmed">23193182</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Meyel DJ, Thomas JB, Agulnick AD. Ssdp proteins bind to LIM-interacting co-factors and regulate the activity of LIM-homeodomain protein complexes in vivo. Development. 2003;130(9):1915–1925. doi:10.1242/dev.00389.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.00389</ArticleId>
            <ArticleId IdType="pubmed">12642495</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gungor C, Taniguchi-Ishigaki N, Ma H, Drung A, Tursun B, Ostendorff HP, Bossenz M, Becker CG, Becker T, Bach I, et al. Proteasomal selection of multiprotein complexes recruited by LIM homeodomain transcription factors. Proc Natl Acad Sci U S A. 2007;104(38):15000–15005. doi:10.1073/pnas.0703738104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0703738104</ArticleId>
            <ArticleId IdType="pmc">PMC1986602</ArticleId>
            <ArticleId IdType="pubmed">17848518</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galloway JR, Bethea M, Liu Y, Underwood R, Mobley JA, Hunter CS. SSBP3 interacts with islet-1 and Ldb1 to impact pancreatic beta-cell target genes. Mol Endocrinol. 2015;29:1774–1786. doi:10.1210/me.2015-1165.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/me.2015-1165</ArticleId>
            <ArticleId IdType="pmc">PMC4664226</ArticleId>
            <ArticleId IdType="pubmed">26495868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rabaglia ME, Gray-Keller MP, Frey BL, Shortreed MR, Smith LM, Attie AD. Alpha-ketoisocaproate-induced hypersecretion of insulin by islets from diabetes-susceptible mice. Am J Physiol Endocrinol Metab. 2005;289:E218–24. doi:10.1152/ajpendo.00573.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpendo.00573.2004</ArticleId>
            <ArticleId IdType="pubmed">15741243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ren G, Bhatnagar S, Hahn DJ, Kim JA. Long-chain acyl-CoA synthetase-1 mediates the palmitic acid-induced inflammatory response in human aortic endothelial cells. Am J Physiol Endocrinol Metab. 2020;319:E893–E903. doi:10.1152/ajpendo.00117.2020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpendo.00117.2020</ArticleId>
            <ArticleId IdType="pmc">PMC7790120</ArticleId>
            <ArticleId IdType="pubmed">32954825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hong K, Xu G, Grayson TB, Shalev A. Cytokines regulate beta-cell thioredoxin-interacting protein (TXNIP) via distinct mechanisms and pathways. J Biol Chem. 2016;291:8428–8439. doi:10.1074/jbc.M115.698365.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M115.698365</ArticleId>
            <ArticleId IdType="pmc">PMC4861417</ArticleId>
            <ArticleId IdType="pubmed">26858253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu G, Thielen LA, Chen J, Grayson TB, Grimes T, Bridges SL Jr., Tse HM, Smith B, Patel R, Li P, et al. Serum miR-204 is an early biomarker of type 1 diabetes-associated pancreatic beta-cell loss. Am J Physiol Endocrinol Metab. 2019;317:E723–E30. doi:10.1152/ajpendo.00122.2019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpendo.00122.2019</ArticleId>
            <ArticleId IdType="pmc">PMC6842918</ArticleId>
            <ArticleId IdType="pubmed">31408375</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McKenna B, Guo M, Reynolds A, Hara M, Stein R. Dynamic recruitment of functionally distinct Swi/Snf chromatin remodeling complexes modulates Pdx1 Activity in islet beta cells. Cell Rep. 2015;10:2032–2042. doi:10.1016/j.celrep.2015.02.054.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2015.02.054</ArticleId>
            <ArticleId IdType="pmc">PMC4651178</ArticleId>
            <ArticleId IdType="pubmed">25801033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu G, Chen J, Jing G, Shalev A. Thioredoxin-interacting protein regulates insulin transcription through microRNA-204. Nat Med. 2013;19(9):1141–1146. doi:10.1038/nm.3287.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.3287</ArticleId>
            <ArticleId IdType="pmc">PMC3835787</ArticleId>
            <ArticleId IdType="pubmed">23975026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poitout V, Hagman D, Stein R, Artner I, Robertson RP, Harmon JS. Regulation of the insulin gene by glucose and fatty acids. J Nutr. 2006;136(4):873–876. doi:10.1093/jn/136.4.873.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jn/136.4.873</ArticleId>
            <ArticleId IdType="pmc">PMC1853259</ArticleId>
            <ArticleId IdType="pubmed">16549443</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poitout V, Robertson RP. Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev. 2008;29:351–366. doi:10.1210/er.2007-0023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/er.2007-0023</ArticleId>
            <ArticleId IdType="pmc">PMC2528858</ArticleId>
            <ArticleId IdType="pubmed">18048763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hagman DK, Hays LB, Parazzoli SD, Poitout V. Palmitate inhibits insulin gene expression by altering PDX-1 nuclear localization and reducing MafA expression in isolated rat islets of Langerhans. J Biol Chem. 2005;280(37):32413–32418. doi:10.1074/jbc.M506000200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M506000200</ArticleId>
            <ArticleId IdType="pmc">PMC1361267</ArticleId>
            <ArticleId IdType="pubmed">15944145</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wade AK, Liu Y, Bethea MM, Toren E, Tse HM, Hunter CS. LIM-domain transcription complexes interact with ring-finger ubiquitin ligases and thereby impact islet beta-cell function. J Biol Chem. 2019;294(31):11728–11740. doi:10.1074/jbc.RA118.006985.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.RA118.006985</ArticleId>
            <ArticleId IdType="pmc">PMC6682733</ArticleId>
            <ArticleId IdType="pubmed">31186351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karlsson O, Thor S, Norberg T, Ohlsson H, Edlund T. Insulin gene enhancer binding protein Isl-1 is a member of a novel class of proteins containing both a homeo- and a Cys-His domain. Nature. 1990;344:879–882. doi:10.1038/344879a0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/344879a0</ArticleId>
            <ArticleId IdType="pubmed">1691825</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
